BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15269480)

  • 1. Role of magnetic resonance perfusion studies in moyamoya disease.
    Khanna PC; Lath C; Gadewar SB; Patkar DP
    Neurol India; 2004 Jun; 52(2):238-40. PubMed ID: 15269480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya disease--magnetic resonance imaging and magnetic resonance angiographic features.
    Gupta R; Kumari R; Gupta N; Prakash A; Chowdhury V
    J Indian Med Assoc; 2006 Apr; 104(4):198-9. PubMed ID: 16910328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal time-to-peak changes on perfusion MRI in children with Moyamoya disease: correlation with conventional angiography.
    Choi HS; Kim DS; Shim KW; Kim J; Kim ES; Lee SK
    Acta Radiol; 2011 Jul; 52(6):675-9. PubMed ID: 21525108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report.
    Wityk RJ; Hillis A; Beauchamp N; Barker PB; Rigamonti D
    Neurosurgery; 2002 Dec; 51(6):1499-505; discussion 1506. PubMed ID: 12445358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization.
    Sakamoto S; Ohba S; Shibukawa M; Kiura Y; Arita K; Kurisu K
    Acta Neurochir (Wien); 2006 Jan; 148(1):77-81; discussion 81. PubMed ID: 16184319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy].
    Yanagawa Y; Ogura M; Okuda E; Okunaga T; Takahata H; Nakamura M
    No Shinkei Geka; 2003 Mar; 31(3):275-9. PubMed ID: 12684981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease].
    Nanba R; Kuroda S; Takeda M; Shichinohe H; Nakayama N; Ishikawa T; Houkin K; Iwasaki Y
    No Shinkei Geka; 2003 Dec; 31(12):1291-5. PubMed ID: 14719442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moyamoya disease in children.
    Takanashi J
    Brain Dev; 2011 Mar; 33(3):229-34. PubMed ID: 20932697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya disease associated with hereditary spherocytosis.
    Vo Van P; Sabouraud P; Mac G; Abely M; Bednarek N
    Pediatr Neurol; 2011 Jan; 44(1):69-71. PubMed ID: 21147392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moyamoya syndrome with protein S deficiency.
    Akgün D; YiLmaz S; Senbil N; Aslan B; Gürer YY
    Eur J Paediatr Neurol; 2000; 4(4):185-8. PubMed ID: 11008263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Repeated, reversible MR angiographic findings in pediatric moyamoya disease: case report].
    Osanai T; Kuroda S; Ishikawa T; Kudo K; Terae S; Isobe M; Iwasaki Y
    No Shinkei Geka; 2006 Apr; 34(4):403-7. PubMed ID: 16613222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
    Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
    Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
    Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging--correlation with clinical outcome after revascularization surgery.
    Yun TJ; Cheon JE; Na DG; Kim WS; Kim IO; Chang KH; Yeon KM; Song IC; Wang KC
    Radiology; 2009 Apr; 251(1):216-23. PubMed ID: 19332853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical manifestations of infantile moyamoya disease].
    Kuroda S; Nanba R; Ishikawa T; Houkin K; Kamiyama H; Iwasaki Y
    No Shinkei Geka; 2003 Oct; 31(10):1073-8. PubMed ID: 14598644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal enhancement in petients with moyamoya disease: correlation with perfusion imaging.
    Chung PW; Park KY
    Neurology; 2009 May; 72(21):1872-3. PubMed ID: 19470971
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of moyamoya disease on magnetic resonance imaging: are flow voids in the basal ganglia an essential criterion for definitive diagnosis?
    Mikami T; Sugino T; Ohtaki S; Houkin K; Mikuni N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):862-8. PubMed ID: 22939199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presumed perinatal stroke in a child with Down syndrome and moyamoya disease.
    Pysden K; Fallon P; Moorthy B; Ganesan V
    Dev Med Child Neurol; 2010 Feb; 52(2):212-4. PubMed ID: 19583743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness and limitation of MR imaging and MR angiography in diagnosis of juvenile moyamoya disease].
    Aoki T; Matsuzawa H; Houkin K; Kamiyama H; Abe H; Miyasaka K; Saito H
    No Shinkei Geka; 1993 Apr; 21(4):305-11. PubMed ID: 8474584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.